Glenmark Pharmaceuticals Ltd on Monday said its arm Glenmark Specialty SA has received approval from China's National Medical ...

(The Place Advertiser) - Dr. Doug Jones says people don't have to live with food allergies: they can live without them.

The study found that a peanut patch treatment—called epicutaneous immunotherapy, or EPIT—continued to help toddlers safely ...

New evidence suggests that introducing common sources of food allergies in the first year of life is associated with reductions in new cases in children. But prevention is only part of the story.

Allergy Therapeutics ( (GB:AGY) ) has provided an update. Allergy Therapeutics has commenced patient screening for the second year of its Phase III G308 trial, which evaluates the long-term efficacy ...

Dose-intense escalation, used with a probiotic, induces sustained unresponsiveness in more than 75% of those completing ...

People with extreme, life-threatening allergic reactions might do as well to use a nasal spray as to jab themselves in a ...

According to the CDC, an estimated 1 in 13 children have food allergies. And at least 2 in 5 children, or 40 percent, have ...

Children whose eczema developed earlier, lasted longer and was more severe were less likely to outgrow their food allergy, ...

Benralizumab is an anti-IL-5Ra antibody that causes a nearly complete depletion of eosinophils and has demonstrated ...

Delgocitinib has emerged as a promising treatment for CHE, addressing unmet needs and enhancing understanding of this complex condition, notes Raj Chovatiya, MD, PhD, MSCI.